227 related articles for article (PubMed ID: 26258678)
21. Antiarrhythmic prophylaxis vs warfarin anticoagulation to prevent thromboembolic events among patients with atrial fibrillation. A decision analysis.
Middlekauff HR; Stevenson WG; Gornbein JA
Arch Intern Med; 1995 May; 155(9):913-20. PubMed ID: 7726699
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of time in therapeutic range in anticoagulated patients: a single-center, retrospective, observational study.
Caldeira D; Cruz I; Morgado G; Stuart B; Gomes C; Martins C; João I; Pereira H
BMC Res Notes; 2014 Dec; 7():891. PubMed ID: 25491419
[TBL] [Abstract][Full Text] [Related]
23. Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range.
Connolly SJ; Pogue J; Eikelboom J; Flaker G; Commerford P; Franzosi MG; Healey JS; Yusuf S;
Circulation; 2008 Nov; 118(20):2029-37. PubMed ID: 18955670
[TBL] [Abstract][Full Text] [Related]
24. A prospective, multi-center cohort study: investigating the ability of warfarin-treated patients to predict their INR.
McNamara K; Witry M; Bryant G; Koenigsfeld C; Lehman N; Logemann C; Mormann M; Rueber A; Herring M; Hoehns JD
Clin Res Cardiol; 2019 Feb; 108(2):212-217. PubMed ID: 30091085
[TBL] [Abstract][Full Text] [Related]
25. Quality of oral anticoagulation control in Chinese patients with non-valvular atrial fibrillation: a prospective controlled study.
Li Y; Yu J; Kuang Y; Wu C; Yang L; Fang Q; Pei Q; Yang G
Curr Med Res Opin; 2020 Sep; 36(9):1433-1439. PubMed ID: 32677855
[TBL] [Abstract][Full Text] [Related]
26. Pilot study of a novel patient self-management program for warfarin therapy using venipuncture-acquired international normalized ratio monitoring.
Simmons BJ; Jenner KM; Delate T; Clark NP; Kurz D; Witt DM
Pharmacotherapy; 2012 Dec; 32(12):1078-84. PubMed ID: 23112110
[TBL] [Abstract][Full Text] [Related]
27. Quality of vitamin K antagonist oral anticoagulation in 322 patients with atrial fibrillation - real-life data from a survey in Eastern Switzerland.
Maeder MT; König T; Bogdanovic S; Schneider I; Eugster W; Ammann P; König M; Beer J; Rickli H
Swiss Med Wkly; 2017; 147():w14503. PubMed ID: 29039622
[TBL] [Abstract][Full Text] [Related]
28. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
[TBL] [Abstract][Full Text] [Related]
29. Anticoagulation control quality affects the D-dimer levels of atrial fibrillation patients.
Nakatani Y; Mizumaki K; Nishida K; Hirai T; Sakabe M; Oda Y; Joho S; Fujiki A; Nozawa T; Inoue H
Circ J; 2012; 76(2):317-21. PubMed ID: 22185714
[TBL] [Abstract][Full Text] [Related]
30. Use of the SAMe-TT2R2 Score to Predict Good Anticoagulation Control with Warfarin in Chinese Patients with Atrial Fibrillation: Relationship to Ischemic Stroke Incidence.
Chan PH; Hai JJ; Chan EW; Li WH; Tse HF; Wong IC; Lip GY; Siu CW
PLoS One; 2016; 11(3):e0150674. PubMed ID: 27010633
[TBL] [Abstract][Full Text] [Related]
31. [Time in therapeutic range (TTR) and follow-up of patients on vitamin K antagonist: A cohort analysis].
Valdelièvre E; Quéré I; Caré B; Laroche JP; Schved JF
J Med Vasc; 2018 May; 43(3):155-162. PubMed ID: 29754725
[TBL] [Abstract][Full Text] [Related]
32. Depression as a Driving Force for Low Time in Therapeutic Range and Dementia in Patients With and Without Atrial Fibrillation.
Rizzi SA; Knight S; May HT; Woller SC; Stevens SM; Steinberg BA; Bair TL; Anderson JL; Muhlestein JB; Knowlton KU; Bunch TJ
Am J Cardiol; 2021 Aug; 153():58-64. PubMed ID: 34176597
[TBL] [Abstract][Full Text] [Related]
33. Time in therapeutic range and stability over time for warfarin users in clinical practice: a retrospective cohort study using linked routinely collected health data in Alberta, Canada.
McAlister FA; Wiebe N; Hemmelgarn BR
BMJ Open; 2018 Jan; 8(1):e016980. PubMed ID: 29382672
[TBL] [Abstract][Full Text] [Related]
34. Quality of anticoagulation care in patients discharged from a pharmacist-managed anticoagulation clinic after stabilization of warfarin therapy.
Garwood CL; Dumo P; Baringhaus SN; Laban KM
Pharmacotherapy; 2008 Jan; 28(1):20-6. PubMed ID: 18154470
[TBL] [Abstract][Full Text] [Related]
35. Quality of warfarin control in atrial fibrillation patients in South East Queensland, Australia.
Bernaitis N; Badrick T; Davey AK; Anoopkumar-Dukie S
Intern Med J; 2016 Aug; 46(8):925-31. PubMed ID: 27040159
[TBL] [Abstract][Full Text] [Related]
36. Anticoagulation control and cost of monitoring of older patients on chronic warfarin therapy in three settings in North East England.
Abohelaika S; Kamali F; Avery P; Robinson B; Kesteven P; Wynne H
Age Ageing; 2014 Sep; 43(5):708-11. PubMed ID: 24947831
[TBL] [Abstract][Full Text] [Related]
37. Time in therapeutic range: Warfarin anticoagulation for atrial fibrillation in a community-based practice.
Gateman D; Trojnar ME; Agarwal G
Can Fam Physician; 2017 Oct; 63(10):e425-e431. PubMed ID: 29025819
[TBL] [Abstract][Full Text] [Related]
38. Amiodarone, anticoagulation, and clinical events in patients with atrial fibrillation: insights from the ARISTOTLE trial.
Flaker G; Lopes RD; Hylek E; Wojdyla DM; Thomas L; Al-Khatib SM; Sullivan RM; Hohnloser SH; Garcia D; Hanna M; Amerena J; Harjola VP; Dorian P; Avezum A; Keltai M; Wallentin L; Granger CB;
J Am Coll Cardiol; 2014 Oct; 64(15):1541-50. PubMed ID: 25301455
[TBL] [Abstract][Full Text] [Related]
39. Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculA.
Wieloch M; Själander A; Frykman V; Rosenqvist M; Eriksson N; Svensson PJ
Eur Heart J; 2011 Sep; 32(18):2282-9. PubMed ID: 21616951
[TBL] [Abstract][Full Text] [Related]
40. International normalized ratio stability in warfarin-experienced patients with nonvalvular atrial fibrillation.
Nelson WW; Desai S; Damaraju CV; Lu L; Fields LE; Wildgoose P; Schein JR
Am J Cardiovasc Drugs; 2015 Jun; 15(3):205-11. PubMed ID: 25944648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
